Maimon Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,327
Closed -$1.18M 83
2026
Q1
$1.18M Hold
1,327
1.03% 29
2025
Q4
$1.43M Buy
+1,327
New +$1.27M 1.33% 27

Other funds holding LLY

Maimon Wealth Management's LLY Position: Q2 2026 in Review

Maimon Wealth Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 1,327 shares — an estimated $1.18M sold.

Maimon Wealth Management first reported a position in LLY in Q4 2025 and held it in 2 quarters. The position peaked at $1.43M in Q4 2025. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Maimon Wealth Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Maimon Wealth Management sold 1,327 Eli Lilly shares in Q2 2026, an estimated $1.18M.
  • Maimon Wealth Management first reported a position in Eli Lilly in Q4 2025 and held it in 2 quarters.
  • Maimon Wealth Management's Eli Lilly position peaked at $1.43M in Q4 2025.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Maimon Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.